Age at menopause may now be predicted more realistically according to a new study accepted for publication in the Journal of Clinical Endocrinology & Metabolism (JCEM). The study revealed that anti-Müllerian hormone (AMH) levels are related to the onset of menopause and are able to specify a woman’s reproductive age more accurately than chronological age alone.
The levels of AMH in the blood reflect the number of small follicles present in a woman’s ovaries. This follicle stock enables reproduction by ensuring monthly ovulations. Depletion of the stock leads to menopause, which normally occurs between 40 and 60 years of age.
“Couples often postpone childbearing until after age thirty, even though variation in menopausal age and corresponding variation in natural fertility means that some women are sterile as early as their thirties,” say Dr. Jeroen van Disseldorp and Dr Frank Broekmans of the University Medical Center Utrecht in Utrecht, the Netherlands. “Knowing when menopause may occur could greatly impact childbearing decisions and our findings show that such knowledge may now be available from AMH levels.”
For this study, AMH levels were measured in 144 healthy, fertile women and the data were used to determine an estimate of mean AMH as a function of age. This information was then used to estimate the distribution of the age of menopause in a sample of 3,384 women between the ages of 50 and 70. Researchers were then able to develop a model based on AMH level and age that could predict age at menopause for individual women.
Prediction for younger women may be more problematic since observed AMH levels were underrepresented at younger ages, and a recent study in mice show that mean AMH levels do not decline at young ages.
Source: The Endocrine Society
Related stories:
Smoking riskier to women's hearts than men's
(AP) -- Women typically get heart disease much later than men, but not if they smoke, researchers said Tuesday. In fact, women who smoke have heart attacks nearly 14 years earlier than women who don't smoke, Norwegian doctors reported in a study presented to the European Society of Cardiology. For men, the gap is not so dramatic; male smokers have heart attacks about six years earlier than men who don't smoke.
Gender differences and heart disease
Women may respond less favorably than men to cardiovascular disease (CV) drug-treatments for enlarged heart, according to NewYork-Presbyterian Hospital/Weill Cornell Medical Center physician-scientists.
New photo 'op' for ovaries may solve some mysteries of infertility
What causes a woman's eggs to deteriorate in quality with age, and can that be reversed?How does the ovary choose an egg -- out of a stash of roughly one million -- to release for ovulation? And can the ovary be influenced to pick a "good" quality egg rather than one with chromosomal damage?
Oocyte-specific gene mutations cause premature ovarian failure
Mutations in a gene called FIGLA cause premature ovarian failure in at least a percentage of women who suffer from the disorder, said researchers from Baylor College of Medicine in Houston and Shandong University in China in a report that appears online today in the
American Journal of Human Genetics.
Girls, young women can cut risk of early breast cancer through regular exercise
Mothers, here’s another reason to encourage your daughters to be physically active: Girls and young women who exercise regularly between the ages of 12 and 35 have a substantially lower risk of breast cancer before menopause compared to those who are less active, new research shows.
Molecular 'clock' could predict risk for developing breast cancer
A chemical reaction in genes that control breast cancer provides a molecular clock that could one day help researchers more accurately determine a woman’s risk for developing breast cancer and provide a new approach for treatment, UT Southwestern Medical Center researchers have found.
Treatment advances for fibroids, menopause
Women with fibroids and endometriosis facing the possibility of hysterectomy may now choose less invasive treatment options to preserve fertility, according to Yale professor Aydin Arici, M.D., who will direct a scientific session exploring these alternatives at the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical Meeting May 3-7 in New Orleans, Louisiana.
Study shows gene variations may predict risk of breast cancer in women
According to a recent study, led by Virginia Kaklamani, MD, an oncologist at Northwestern Memorial Hospital and assistant professor of medicine, Northwestern University Feinberg School of Medicine, variations of the adiponectin gene, which regulates a number of metabolic processes, may increase a woman’s risk of developing breast cancer. This discovery is an important step forward in cancer genetics research, as it could help experts develop a future genetic testing model to more accurately predict a woman’s risk of developing breast cancer.